Subclinical myocardial dysfunction in Rett syndrome

European Heart Journal Cardiovascular Imaging

Volumn 13, Issue 4, 2012, Pages 339-345

  De Felice, Claudio ^a   Maffei, Silvia ^a   Signorini, Cinzia ^b   Leoncini, Silvia ^b   Lunghetti, Stefano ^a   Valacchi, Giuseppe ^c,d   D'Esposito, Maurizio ^e,f   Filosa, Stefania ^e,f   Ragione, Floriana Della ^e,f   Butera, Gianfranco ^g   Favilli, Roberto ^a   Ciccoli, Lucia ^b   Hayek, Joussef ^a  

^a UNIVERSITY HOSPITAL OF SIENA   (Italy)

^b UNIVERSITY OF SIENA   (Italy)

^c UNIVERSITY OF FERRARA   (Italy)

^d Kyung Hee University   (South Korea)

^e INSTITUTE OF GENETICS AND BIOPHYSICS ADRIANO BUZZATI TRAVERSO   (Italy)

^f IRCCS NEUROMED   (Italy)

^g IRCCS   (Italy)

Author keywords

Echocardiography; MeCP2; Myocardial function; Oxidative stress; Perfusion index; Rett syndrome

Indexed keywords

IRON; ISOPROSTANE DERIVATIVE; METHYL CPG BINDING PROTEIN 2;

ADOLESCENT; ARTICLE; CARDIOVASCULAR PARAMETERS; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE ASSOCIATION; ECHOCARDIOGRAPHY; FEMALE; HEART DISEASE; HEART FUNCTION; HEART LEFT VENTRICLE EJECTION FRACTION; HEART VENTRICLE FUNCTION; HUMAN; LEFT VENTRICULAR SYSTOLIC DYSFUNCTION; MYOCARDIAL DISEASE; OXIDATIVE STRESS; PRIORITY JOURNAL; RETT SYNDROME; SCHOOL CHILD; SYSTOLIC BLOOD PRESSURE;

ADOLESCENT; CASE-CONTROL STUDIES; CHI-SQUARE DISTRIBUTION; CHILD; CONFIDENCE INTERVALS; FEMALE; HEALTH STATUS INDICATORS; HUMANS; METHYL-CPG-BINDING PROTEIN 2; MYOCARDIUM; OXIDATIVE STRESS; OXIMETRY; RETT SYNDROME; RISK ASSESSMENT; STATISTICS AS TOPIC;

EID: 84863853406     PISSN: 20472404     EISSN: None     Source Type: Journal    
DOI: 10.1093/ejechocard/jer256     Document Type: Article

References (38)

1. Chahrour M, Jung SY, Shaw C, Zhou X, Wong ST, Qin J et al. MeCP2, a key contributor to neurological disease, activates and represses transcription. Science 2008;320:1224-9. (Pubitemid 351929512)
2. Amir RE, Van den Veyver IB, Wan M, Tran CQ, Francke U, Zoghbi HY. Rett syndrome is caused by mutation in X - linked MECP2, encoding methyl-CpG-binding protein 2. Nat Genet 1999;23:185-8. (Pubitemid 29455390)
3. Chahrour M, Zoghbi HY. The story of Rett syndrome: from clinic to neurobiology. Neuron 2007;56:422-37. (Pubitemid 350026269)
4. Mari F, Azimonti S, Bertani I, Bolognese F, Colombo E, Caselli R et al. CDKL5 belongs to the same molecular pathway of MeCP2 and it is responsible for the early-onset seizure variant of Rett syndrome. Hum Mol Genet 2005;14:1935-46. (Pubitemid 41418030)
5. Ariani F, Hayek G, Rondinella D, Artuso R, Mencarelli MA, Spanhol-Rosseto A et al. FOXG1 is responsible for the congenital variant of Rett syndrome. Am J Hum Genet 2008;83:89-93.
6. Neul JL, Kaufmann WE, Glaze DG, Christodoulou J, Clarke AJ, Bahi-Buisson N et al. RettSearch Consortium. Rett syndrome: revised diagnostic criteria and nomenclature. Ann Neurol 2010;68:944-50.
7. Hagberg B. Clinical manifestations and stages of Rett syndrome. Ment Retard Dev Disabil Res Rev 2002;8:61-5. (Pubitemid 34606514)
8. De Felice C, Guazzi G, Rossi M, Ciccoli L, Signorini C, Leoncini S et al. Unrecognized lung disease in classic Rett syndrome: a physiologic and high-resolution CT imaging study. Chest 2010;138:386-92.
9. Sekul EA, Moak JP, Schultz RJ, Glaze DG, Dunn JK, Percy AK. Electrocardiographic findings in Rett syndrome: an explanation for sudden death? J Pediatr 1994;125: 80-2. (Pubitemid 24225185)
10. Guideri F, Acampa M, Hayek G, Zappella M, Di Perri T. Reduced heart rate variability in patients affected with Rett syndrome. A possible explanation for sudden death. Neuropediatrics 1999;30:146-8. (Pubitemid 29366686)
11. Kerr AM, Armstrong DD, Prescott RJ, Doyle D, Kearney DL. Rett syndrome: analysis of deaths in the British survey. Eur Child Adolesc Psychiatry 1997;6(Suppl. 1):71-4. (Pubitemid 28027156)
12. Acampa M, Guideri F. Cardiac disease and Rett syndrome. Arch Dis Child 2006;91: 440-3. (Pubitemid 43672376)
13. Kou CY, Lau SL, Au KW, Leung PY, Chim SS, Fung KP et al. Epigenetic regulation of neonatal cardiomyocytes differentiation. Biochem Biophys Res Commun 2010; 400:278-83.
14. Griendling KK, FitzGerald GA. Oxidative stress and cardiovascular injury Part I: basic mechanisms and in vivo monitoring of ROS. Circulation 2003;108:1912-6. (Pubitemid 37296532)
15. Chen L, Einbinder E, Zhang Q, Hasday J, Balke CW, Scharf SM. Oxidative stress and left ventricular function with chronic intermittent hypoxia in rats. Am J Respir Crit Care Med 2005;172:915-20. (Pubitemid 41369077)
16. Mosteller RD. Simplified calculation of body surface area. N Engl J Med 1987;317: 1098.
17. Lam TK, Leung DT. More on simplified calculation of body-surface area. N Engl J Med 1988;318:1130. (Pubitemid 18098619)
18. De Felice C, Latini G, Vacca P, Kopotic RJ. The pulse oximeter perfusion index as a predictor for high illness severity in neonates. Eur J Pediatr 2002;161:561-2.
19. Cannesson M, Slieker J, Desebbe O, Bauer C, Chiari P, Hénaine R et al. The ability of a novel algorithm for automatic estimation of the respiratory variations in arterial pulse pressure to monitor fluid responsiveness in the operating room. Anesth Analg 2008;106:1195-200. (Pubitemid 351450545)
20. Nishimura RA, Tajik AJ. Evaluation of diastolic filling of left ventricle in health and disease: Doppler echocardiography is the clinician's Rosetta Stone. J Am Coll Cardiol 1997;30:8-18. (Pubitemid 27357121)
21. Nagueh SF, Appleton CP, Gillebert TC, Marino PN, Oh JK, Smiseth OA et al. Recommendations for the evaluation of left ventricular diastolic function by echocardiography. J Am Soc Echocardiogr 2009;22:107-33.
22. Henein MY, Gibson DG. Long axis function in disease. Heart 1999;81:229-31.
23. Nagueh SF, Middleton KJ, Kopelen HA, Zoghbi WA, Quiñones MA. Doppler tissue imaging: a noninvasive technique for evaluation of left ventricular relaxation and estimation of filling pressures. J Am Coll Cardiol 1997;30:1527-33. (Pubitemid 27486472)
24. Ommen SR, Nishimura RA, Appleton CP, Miller FA, Oh JK, Redfield MM et al. Clinical utility of Doppler echocardiography and tissue Doppler imaging in the estimation of left ventricular filling pressures: a comparative simultaneous Doppler-catheterization study. Circulation 2000;102:1788-94.
25. De Felice C, Ciccoli L, Leoncini S, Signorini C, Rossi M, Vannuccini L et al. Systemic oxidative stress in classic Rett syndrome. Free Radic Biol Med 2009;47:440-8.
26. Signorini C, Comporti M, Giorgi G. Ion trap tandem mass spectrometric determination of F2-isoprostanes. J Mass Spectrom 2003;38:1067-74. (Pubitemid 37407701)
27. Goldeberg LR, Jessup M. Stage B heart failure. management of asymptomatic left ventricular systolic dysfunction. Circulation 2006;113:2851-60. (Pubitemid 44305298)
28. Oh JK, Hatle L, Tajik AJ, Little WC. Diastolic heart failure can be diagnosed by comprehensive two-dimensional and Doppler echocardiography. J Am Coll Cardiol 2006;47:500-6. (Pubitemid 43170836)
29. Mukoyama M, Nakao K, Hosoda K, Suga S, Saito Y, Ogawa Y et al. Brain natriuretic peptide as a novel cardiac hormone in humans. Evidence for an exquisite dual natriuretic peptide system, atrial natriuretic peptide and brain natriuretic peptide. J Clin Invest 1991;87:1402-12.
30. Yasue H, Yoshimura M, Sumida H, Kikuta K, Kugiyama K, Jougasaki M et al. Localization and mechanism of secretion of B-type natriuretic peptide in comparison with those of A-type natriuretic peptide in normal subjects and patients with heart failure. Circulation 1994;90:195-203. (Pubitemid 24203680)
31. Hall C. Essential biochemistry and physiology of (NT-pro)BNP. Eur J Heart Fail 2004;6:257-60. (Pubitemid 38253043)
32. Welisch E, Norozi K, Rauch R. N-terminal pro-brain natriuretic peptide level as a screening tool for cardiac involvement in paediatric diseases of extracardiac origin. Clin Res Cardiol 2011;100:723-30.
33. Milne GL, Musiek ES, Morrow JD. F2-isoprostanes as markers of oxidative stress in vivo: an overview. Biomarkers 2005;10(Suppl. 1):10-23.
34. Bird A. The methyl-CpG-binding protein MeCP2 and neurological disease. Biochem Soc Trans 2008;36(Pt 4):575-83.
35. Alvarez-Saavedra M, Carrasco L, Sura-Trueba S, Demarchi Aiello V, Walz K, Neto JX et al. Elevated expression of MeCP2 in cardiac and skeletal tissues is detrimental for normal development. Hum Mol Genet 2010;19:2177-90.
36. Kriaucionis S, Paterson A, Curtis J, Guy J, Macleod N, Bird A. Gene expression analysis exposes mitochondrial abnormalities in a mouse model of Rett Syndrome. Mol Cell Biol 2006;26:5033-42. (Pubitemid 43955817)
37. Heilstedt HA, Shahbazian MD, Lee B. Infantile hypotonia as a presentation of Rett syndrome. Am J Med Genet 2002;111:238-42. (Pubitemid 34815446)
38. Eeg-Olofsson O, al-Zuhair AG, Teebi AS, al-Essa MM. Rett syndrome: genetic clues based on mitochondrial changes in muscle. Am J Med Genet 1989;32: 142-4. (Pubitemid 19049829)